Common Stock, Shares Authorized of Eiger BioPharmaceuticals, Inc. from 31 Dec 2013 to 31 Dec 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Dec 2013 to 31 Dec 2023.
  • Eiger BioPharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending 31 Dec 2023 was 200,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Eiger BioPharmaceuticals, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 200,000,000 0 0% 31 Dec 2023 10-K 08 Apr 2024 2023 FY
Q4 2022 200,000,000 0 0% 31 Dec 2022 10-K 08 Apr 2024 2023 FY
Q4 2021 200,000,000 0 0% 31 Dec 2021 10-K 17 Mar 2023 2022 FY
Q4 2020 200,000,000 0 0% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q4 2019 200,000,000 0 0% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q4 2018 200,000,000 0 0% 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q4 2017 200,000,000 0 0% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q4 2016 200,000,000 +194,048,513 +3261% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q1 2016 200,000,000 +196,726,683 +6010% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 5,951,487 +3,815,954 +179% 31 Dec 2015 10-K 23 Mar 2017 2016 FY
Q3 2015 200,000,000 0 0% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 200,000,000 0 0% 30 Jun 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 3,273,317 -196,726,683 -98% 31 Mar 2015 8-K/A 17 Jun 2016
Q4 2014 2,135,533 -177,864,467 -99% 31 Dec 2014 8-K/A 17 Jun 2016
Q3 2014 200,000,000 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 200,000,000 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 200,000,000 31 Mar 2014 10-Q 13 May 2014 2014 Q1
Q4 2013 180,000,000 31 Dec 2013 10-K 31 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.